Viracta Therapeutics Stock (NASDAQ: VIRX) stock price, news, charts, stock research, profile.
You can purchase shares of Viracta Therapeutics (NASDAQ:VIRX) through any online brokerage.
Other companies in Viracta Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN) and Quoin Pharmaceuticals (NASDAQ:QNRX).
Viracta Therapeutics has a consensus price target of $5.04.
The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $0.2054 last updated January 3, 2025 at 7:57 PM EST.
There are no upcoming dividends for Viracta Therapeutics.
Viracta Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for Viracta Therapeutics.
Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.